Akrotome Imaging Competitors and Similar CompaniesClear all

Akrotome Imaging's competitors and similar companies include Medite, Dignitana, IONIQ Sciences and Leica Biosystems Nussloch.
Akrotome Imaging
Akrotome Imaging
Akrotome Imaging is a company dedicated to the clinical translation of cancer-targeted molecular probes into approaches for surgery and diagnostics.
Medite
Medite
Medite Cancer Diagnostics (formerly CytoCore) is a company that specializes in the development, manufacture and distribution of medical laboratory instruments for pathology, histology, and cytology.
Dignitana
Dignitana
Dignitana is a medical technology company that provides a solution minimizing hair loss during chemotherapy.
IONIQ Sciences
IONIQ Sciences
IONIQ Sciences (formerly known as ProLung) is a company that develops, manufactures, and sells non-invasive medical technology to aid in the early detection and diagnosis of lung cancer.
Leica Biosystems Nussloch
Leica Biosystems Nussloch
Leica Biosystems Nussloch is a medical device company that develops cancer diagnostic products.
Founding Date
Founding Date
2008
Founding Date
1998
Founding Date
1996
Founding Date
N/A
Founding Date
1989
Type
Type
Private
Type
Public
Type
Public
Type
Private
Type
Subsidiary
Tags
Locations
Locations
Cleveland, US HQ
Locations
Orlando, US HQ
Burgdorf, DE
Locations
Lund, SE HQ
Milano, IT
Dallas, US
Locations
Salt Lake City, US HQ
Salt Lake City, US
Locations
Nußloch, DE HQ
Mumbai, IN
Buffalo Grove, US
Deer Park, US
Employees
Employees
2
Employees
696% increase
Employees
26
Employees
13
Employees
38918% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
520.3 k
Valuation ($)
12.1 m
Valuation ($)
N/A
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$6.8m (FY, 2017)
Revenue (est.)
kr89.8m (FY, 2024)
Revenue (est.)
N/A
Revenue (est.)
$254.8m (FY, 2022)
Cost of goods
Cost of goods
N/A
Cost of goods
$6.7m (FY, 2017)
Cost of goods
kr29.6m (FY, 2024)
Cost of goods
N/A
Cost of goods
$154.7m (FY, 2022)
Gross profit
Gross profit
N/A
Gross profit
$162k (FY, 2017)
Gross profit
kr60.3m (FY, 2024)
Gross profit
N/A
Gross profit
$100.1m (FY, 2022)
Net income
Net income
N/A
Net income
($6.8m) (FY, 2017)
Net income
(kr19.2m) (FY, 2024)
Net income
($4.4m) (FY, 2022)
Net income
$32.6m (FY, 2022)
For sources of this data, please see the company profile

View Company Profiles

Medite
HQ
Orlando, US
Employees
69↑ 6% increase

Medite Cancer Diagnostics (formerly CytoCore) is a company that specializes in the development, manufacture and distribution of medical laboratory instruments for pathology, histology, and cytology.

View company
Dignitana
HQ
Lund, SE
Employees
26

Dignitana is a medical technology company that provides a solution minimizing hair loss during chemotherapy.

View company
IONIQ Sciences
HQ
Salt Lake City, US
Employees
13

IONIQ Sciences (formerly known as ProLung) is a company that develops, manufactures, and sells non-invasive medical technology to aid in the early detection and diagnosis of lung cancer.

View company
Leica Biosystems Nussloch
HQ
Nußloch, DE

Leica Biosystems Nussloch is a medical device company that develops cancer diagnostic products.

View company